Ranbaxy recalls 2 batches of antibiotics from US

[OhioChick]

Source: Times of India

15 Apr 2010, 0150 hrs IST,ET Bureau

NEW DELHI: Ranbaxy Laboratories is voluntarily recalling two consignments of one of its antibiotics from the US market, a move that may not impact its revenues but will affect its ongoing problems with the drug regulator, analysts said.

The drugmaker is recalling the antibiotic Amoxicillin & Clavulanate Potassium from the US market because its oral suspension turns brown during reconstitution, instead of white.

“The recall is being carried out at the retail level and conducted with the full knowledge of the USFDA,” a company spokesman said. A total of about 35,000 bottles are in the US retail market and the drug expires in May this year.

Ranbaxy’s share price at the Bombay Stock Exchange (BSE) closed at Rs 460.05, down 0.70%. Ranbaxy is majority owned by Japan’s Daiichi Sankyo.

There were complaints with some of the drugs in two batches but Ranbaxy said its tests showed the drugs to be within specification. The company decided to recall all the lots in question for precautionary reasons, he said.



Read more: http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/Ranbaxy-recalls-2-batches-of-antibiotics-from-US/articleshow/5805837.cms

---

What was the reasoning for not getting meds from Canada, again?

[pinto]

1. Smart voluntary move on Ranbaxy's part. (aside) FYI, they have a Canadian subsidiary, as well.

This recall was apparently initiated by Ranbaxy US, not sure if there were similar action by other subsidiaries, but would expect that they did so as well.

That said, the pharmaceutical company seems to have a spotty record on recalls. I read of 30 - don't know what the industry average is.

:hi: